Back to Search
Start Over
Effects of pre-emptive drug treatment on astrocyte activation in the cuneate nucleus following rat median nerve injury.
- Source :
-
Pain [Pain] 2010 Jan; Vol. 148 (1), pp. 158-166. Date of Electronic Publication: 2009 Dec 01. - Publication Year :
- 2010
-
Abstract
- In this study, we examined the relationship between astrocyte activation in the cuneate nucleus (CN) and behavioral hypersensitivity after chronic constriction injury (CCI) of the median nerve. In addition, we also examined the effects of pre-emptive treatment with a number of drugs on astrocyte activation and hypersensitivity development in this model. Using immunohistochemistry and immunoblotting, little glial fibrillary acidic protein (GFAP; an astrocyte marker) immunoreactivity was detected in the CN of the normal rats. As early as 3 days after CCI, there was a significant increase in GFAP immunoreactivity in the lesion side of CN, and this reached a maximum at 7 days, and was followed by a decline. Counting of GFAP-immunoreactive astrocytes revealed that astrocytic hypertrophy, but not proliferation, contributes to increased GFAP immunoreactivity. Furthermore, microinjection of the glial activation inhibitor, fluorocitrate, into the CN at 3 days after CCI attenuated injury-induced behavioral hypersensitivity in a dose-dependent manner. These results suggest that median nerve injury-induced astrocytic activation in the CN modulated the development of behavioral hypersensitivity. Animals received MK-801 (glutamate N-methyl-d-aspartate (NMDA) receptor antagonist), clonidine (alpha(2)-adrenoreceptor agonist), tetrodotoxin (TTX, sodium channel blocker) or lidocaine (local anesthetic) 30 min prior to median nerve CCI. Pre-treatment with MK-801, TTX, and 2% lidocaine, but not clonidine, attenuated GFAP immunoreactivity and behavioral hypersensitivity following median nerve injury. In conclusion, suppressing reactions to injury, such as the generation of ectopic discharges and activation of NMDA receptors, can decrease astrocyte activation in the CN and attenuate neuropathic pain sensations.<br /> (Copyright 2009 International Association for the Study of Pain. Published by Elsevier B.V. All rights reserved.)
- Subjects :
- Adrenergic alpha-Agonists pharmacology
Animals
Astrocytes drug effects
Citrates pharmacology
Clonidine pharmacology
Disease Models, Animal
Dizocilpine Maleate pharmacology
Excitatory Amino Acid Antagonists pharmacology
Glial Fibrillary Acidic Protein metabolism
Hyperalgesia drug therapy
Lidocaine
Male
Median Neuropathy drug therapy
Medulla Oblongata drug effects
Pain Threshold drug effects
Pain Threshold physiology
Rats
Rats, Sprague-Dawley
Sodium Channel Blockers pharmacology
Tetrodotoxin pharmacology
Time Factors
Up-Regulation drug effects
Up-Regulation physiology
Astrocytes metabolism
Hyperalgesia physiopathology
Median Neuropathy pathology
Medulla Oblongata pathology
Subjects
Details
- Language :
- English
- ISSN :
- 1872-6623
- Volume :
- 148
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- Pain
- Publication Type :
- Academic Journal
- Accession number :
- 19954890
- Full Text :
- https://doi.org/10.1016/j.pain.2009.11.004